Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-06 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |